Projects 2000
- Options for Managing Pharmaceutical Benefits in Ontario. A paper submitted to the Ontario Tri-Partite Committee on Limited-Use Drugs. Willison DJ. October 2000. (download article in PDF format)
- Outcomes Associated with Formulary Cost-Containment Strategies. Willison DJ, Grootendorst P, O'Brien B, Levine MAH, MacLeod SM. August 2000.(download article in PDF format)
- Enbrel® Community Health Outcomes (ECHO) Study. Levine M (PI), Gaebel K, Wang E.
The ECHO study is a post-marketing surveillance study for patients with rheumatoid arthritis using etanercept therapy, Enbrel®, (recombinant human tumor necrosis factor receptor protein) in a community setting.
- Coding Accuracy of Administrative Drug Claims in the Ontario Drug Benefit database. Levy A, Willison D, Sellors C, O'Brien BJ, Grootendorst PV. Father Sean O'Sullivan Research Centre. 2000
Administrative prescription drug claims are an important source of data in pharmacoepidemiology and pharmacoeconomics, yet little is known about the accuracy of these data. To shed light on this issue, we compare a random sample of prescription drug claims for beneficiaries of the Ontario Drug Benefit plan submitted by pharmacies with the corresponding information on ODB claims records to assess (a) whether all claims submitted are recorded by ODB, and (b) whether information on the submitted claims records match information on ODB records.
- Potential Pharmacist-Directed Strategies and Reimbursement Mechanisms to Meet Stakeholder Needs to Improve Drug Therapy Management. Dolovich L, Willison D, Gafni A, Charles C, Perrier D. Sellors C. Sellors J. January 2000
- SPRINT: Study to Prospectively Evaluate Reamed Intramedullary Nails in Tibial Fractures: A multi-center randomized trial (pilot study) Investigators: Guyatt GH (PI) Bhandari M, Walter S, Leighton R, Kreder HM, Schemitsch E, O'Brien B. Sponsor: Orthopaedic Trauma Association 2000